Hospira Commences EPO Phase I U.S. Clinical Trial in Renal Dysfunction Patients With Anemia

Hospira commences EPO Phase I U.S. clinical trial in renal dysfunction patients with anemia
Hospira, Inc., the world leader in generic injectable pharmaceuticals, today announced the start of a U.S. Phase I clinical trial of its biosimilar erythropoietin (EPO) in patients with renal (kidney) dysfunction who have anemia, an important step on the road toward introducing a biosimilar product in the United States. Erythropoietin is a treatment for anemia associated with chronic renal …
Read more on News-Medical-Net

Oncure Medical Corp. & Santa Cruz, CA Cancer Community Benefit From the First Temporary Modular Radiation Oncology …
ENGLEWOOD, Colo. and AVENTURA, Fla., July 26 /PRNewswire/ — Oncure Medical Corp. with Santa Cruz Radiation Oncology in Santa Cruz, CA are near the conclusion of the first placement of a Temporary Radiotherapy Vault (TRV(TM)) by RAD Technology Medical Systems LLC. RAD’s patented system is a portable, modular building equipped with a pre-installed linear accelerator. The shielded enclosure can be …
Read more on redOrbit

China surveys chronic disease prevention capabilities
China has launched a nationwide survey of chronic disease prevention and control capabilities, examining all-level disease control and prevention centers and some selected grassroots healthcare units.
Read more on People’s Daily